The current valuation score of Eledon Pharmaceuticals Inc is 6.38, ranking 340 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.78, which is -330.22% below the recent high of 11.00 and -1604.50% above the recent low of -81.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.